Dianorm M Tablet

Dianorm M Tablet contains Metformin 500 mg (as sustained/extended release) + Gliclazide 80 mg (immediate release). Prescription required.

Type 2 diabetes mellitus to control blood sugar when diet/exercise and single therapy are insufficient

Metformin decreases glucose production in the liver and improves insulin sensitivity. Gliclazide (a sulfonylurea) increases insulin release from pancreatic beta cells, lowering blood sugar.

Take with meals as prescribed (often once or twice daily depending on formulation). Do not crush/chew sustained-release metformin tablets. Do not skip meals to reduce risk of hypoglycaemia; monitor blood glucose.

Hypoglycaemia, nausea, diarrhoea, abdominal pain, metallic taste, dizziness, weight gain

Risk of low blood sugar due to gliclazide, especially with irregular meals, alcohol, or other antidiabetics. Metformin rarely may cause lactic acidosis; avoid in severe kidney impairment and during dehydration/acute illness; monitor kidney function. Temporarily stop before iodinated contrast/surgery as advised by doctor.

Alcohol, iodinated contrast media, insulin/other antidiabetics, fluconazole, beta-blockers, corticosteroids, thiazide diuretics, cimetidine

Store below 30°C, protect from moisture, keep tightly packed in original strip

Glycomet-GP 2 Tablet, Gluconorm-G 2 Tablet, Zomet-G 2 Tablet, Glyciphage-G 2 Tablet, Metformin + Gliclazide combinations (same strength)